WebMarket capitalization of CytomX Therapeutics (CTMX) Market cap: $0.10 Billion As of April 2024 CytomX Therapeutics has a market cap of $0.10 Billion . This makes CytomX Therapeutics the world's 6546th most valuable company by … WebCTMX Stock 12 Months Forecast $2.48 (64.24% Upside) Based on 4 Wall Street analysts offering 12 month price targets for CytomX Therapeutics in the last 3 months. The …
CytomX snags cancer drug deal with Regeneron - San Francisco …
WebApr 14, 2024 · CytomX Therapeutics has a fifty-two week low of $1.17 and a fifty-two week high of $3.02. The company has a market cap of $114.58 million, a price-to-earnings ratio of -1.15 and a beta of 0.65. The stock has a fifty day moving average price of $2.01 and a 200-day moving average price of $1.84. Hedge Funds Weigh In On CytomX Therapeutics WebCytomX Therapeutics stock price target cut to $4 from $16 at Mizuho Jul. 7, 2024 at 7:08 a.m. ET by Tomi Kilgore CytomX Therapeutics downgraded to neutral from buy at … chirala beach location
CytomX Therapeutics CTMX Stock Price, Company Overview
WebJun 10, 2024 · Our data indicates that CytomX Therapeutics, Inc. has a market capitalization of US$458m, and total annual CEO compensation was reported as US$2.8m for the year to December 2024. Notably, that's... WebNov 17, 2024 · That trading point still is far off CytomX's 52-week high of $7.46 per share, but the rise indicates Wall Street's belief that CytomX is heading in the right direction with its third... WebApr 6, 2024 · Share . Today's Range ... Short selling CTMX is an investing strategy that aims to generate trading profit from CytomX Therapeutics as its price is falling. CTMX shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short ... graphic designer at 2u